More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM ADVENT-AML Phase 1B clinical trial update May 15, 2025 at 7:29 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
